Skip to main content
Premium Trial:

Request an Annual Quote

Cognia, Biobase Partner To Distribute Database To Pharma, Biotech Markets


NEW YORK--Cognia Bioinformatics, a privately held firm founded here in 1998, has announced that it will become the exclusive distributor in the US and Canada of an annotated database of transcription regulation information created by Biobase Biological Databases of Braunschweig, Germany. Biobase's Transfac database contains functional annotations of close to 2,500 transcription factors and 8,000 corresponding binding sites. Biobase said it has licensed Transfac to four large undisclosed pharmaceutical companies since the product was commercialized in November 1997. Bruno Larvol, Cognia's founder and CEO, who was previously a bioinformatics consultant at the Wilkerson Group, said, "Our market research suggests that the Transfac database has the potential to become an essential part of the bioinformatics toolkit for all major drug discovery companies."

Filed under

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.